Eccrine sweat glands—concentrated in the scalp, axillae, inguinal folds, and acral skin—function to maintain normal thermal homeostasis and, to a lesser extent, eliminate toxins and drug metabolites.

LONDON--(BUSINESS WIRE)--Technavio has announced their latest drug pipeline analysis report on axillary hyperhidrosis. The report includes a detailed analysis of the pipeline molecules under ...

"Primary Axillary Hyperhidrosis Pipeline 2025"DelveInsight's,“Primary Axillary Hyperhidrosis – Pipeline Insight, 2025,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs ...

DUBLIN--(BUSINESS WIRE)--The "Axillary Hyperhidrosis - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. The Publisher's Pharmaceutical and Healthcare ...

Please provide your email address to receive an email when new articles are posted on . Sofdra (sofpironium) gel 12.45% is the first and only chemical entity for primary axillary hyperhidrosis. The ...

"Axillary hyperhidrosis Pipeline 2025"DelveInsight's,“Axillary Hyperhidrosis - Pipeline Insight, 2025,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Axillary ...

Please provide your email address to receive an email when new articles are posted on . Treatment with sofpironium bromide gel reduced the severity of primary axillary hyperhidrosis in a cohort of ...

DrSkin Plastic Surgery, Regenerative & Medical Spa is pleased to announce the launch of miraDry(R), an FDA-cleared, non-invasive treatment now available at its state-of-the-art facility in Gilbert, ...

Hyperhidrosis is excessive sweating that is more than what is needed to regulate body temperature. About 7 million Americans suffer from hyperhidrosis, a disorder that often goes undiagnosed.

Background: Recent studies demonstrate that botulinum toxin type A (BTX-A) decreases palmar hyperhidrosis. Objective: To evaluate the efficacy and safety of BTX-A for palmar hyperhidrosis. Methods: ...

MENLO PARK, Calif., March 21, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering ...

DelveInsight’s, “Primary Axillary Hyperhidrosis – Pipeline Insight, 2025,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Primary Axillary Hyperhidrosis pipeline ...